I now have a thorough understanding of the paper and all reviewer claims. Let me compose the final consolidated review.

---

## Summary

This paper applies transfer learning with ResNet-50 and EfficientNetV2 to four binary classification tasks on kidney CT images (Cyst vs Normal, Cyst vs Stone, Cyst vs Tumor, Stone vs Tumor) using a public Kaggle dataset. The authors report testing accuracy of up to 100% across all tasks and present a head-to-head comparison of the two architectures. The paper is a method-application study; its intended contribution is the demonstration that off-the-shelf CNNs with ImageNet pretraining can achieve very high accuracy on these specific renal classification problems.

## Strengths

- **Systematic head-to-head comparison of two modern architectures under identical conditions.** The paper trains both ResNet-50 and EfficientNetV2 with the same number of epochs (10), same iterations per epoch (256), same checkpoint mechanism (best validation epoch saved), and the same dataset splits. This fair comparison is detailed in Sections 3.3–3.4 and shows EfficientNetV2 is marginally better, with specific differences reported (e.g., perfect precision except a small drop in Cyst vs Stone for EfficientNetV2; perfect recall except Cyst vs Tumor for ResNet-50).

- **Use of a substantial, publicly available CT dataset with documented origin.** The CT KIDNEY DATASET from Kaggle is sourced from a hospital PACS in Bangladesh and contains thousands of images per task (up to 8,786 for Cyst vs Normal). The paper reports the number of images allocated to training, validation, and testing splits, providing a basis for reproducibility.

- **ROC curves and AUC values provided as an additional evaluation dimension.** Figure 7 reports ROC curves for both models with AUC values close to 1.0 across all four tasks, supporting the discriminative performance claims beyond raw accuracy.

## Weaknesses

### Major

- **Patient-level split not addressed — a critical omission for medical CT data.** The paper describes splitting images into train/val/test sets but gives no indication that images from the same patient were kept together. CT studies routinely produce multiple slices per patient. If slices from the same patient appear in both training and test sets, the evaluation measures image-level similarity rather than generalization to unseen patients. This could artificially inflate accuracy and would invalidate the central claim. The paper must clarify whether a patient-level split was enforced and, if not, the results are not credible.

- **Sample images contain radiologist annotations (red marks), yet no preprocessing to remove such artifacts is described.** The paper states in Section 3.1: "Figure 1 displays sample images of kidneys, with red marks highlighting the regions of interest that radiologists use to make specific diagnoses." If these red marks (or similar annotations, text overlays, or bounding boxes) are present in the training images, a high-capacity CNN could exploit them as shortcut cues rather than learning clinically meaningful features. The paper does not mention any preprocessing step to detect and remove such annotations. This is a well-known confound in medical imaging and must be ruled out before any accuracy claim can be trusted.

- **No baseline comparisons to simpler alternatives.** The paper compares only two high-capacity CNNs (ResNet-50 and EfficientNetV2) against each other and does not report performance of any simpler baselines — e.g., logistic regression on hand-crafted features, a small CNN trained from scratch, or even a majority-class classifier. Given the claimed near-perfect accuracy, these baselines are essential to establish that the transfer learning models are genuinely learning meaningful patterns rather than exploiting dataset artifacts.

- **No statistical confidence measures.** No confidence intervals, standard deviations, or multiple-run averages are reported. The checkpoint mechanism selects the best epoch based on validation performance, and the test result is reported from a single run. Without variance estimates, it is impossible to assess the reliability or stability of the reported near-perfect numbers.

- **Extraordinary claims require extraordinary evidence, and the evidence here is not extraordinary enough.** Medical image classification papers on curated benchmarks rarely exceed 96–98% test accuracy. The paper's prior works section itself cites accuracies in the 84–98% range. A claim of "up to 100% for all cases" is highly unusual and demands rigorous evaluation controls (patient-level splitting, shortcut artifact checks, multiple runs, baseline comparisons) — none of which are provided.

### Minor

- **Section 3.2 (Initialization of Weights) is a generic textbook tutorial** on Xavier and He initialization. It does not describe the specific experimental setup used: which layers were frozen vs. fine-tuned, the learning rate and schedule, the optimizer, the batch size, or the loss function. This is a reproducibility gap.

- **No data augmentation is described.** For a dataset with thousands rather than tens of thousands of images, data augmentation (rotation, flipping, cropping, intensity jitter) is standard practice to improve generalization. Its absence is notable and concerning given the near-perfect test accuracy.

- **Minor inconsistency between the headline claim and the detailed results.** The abstract states "testing accuracy of up to 100% for all cases," while Section 3.4 acknowledges that ResNet-50 had "minor misclassifications" in Cyst vs Tumor and EfficientNetV2 had a "small dip in precision during the Cyst vs Stone task." The phrase "up to 100%" is technically compatible with these imperfections, but the framing is misleading — especially when the actual numerical accuracy values per task are not reported in the text (they appear only in the confusion matrices, which are not text-parsed here).

- **Only 10 epochs of training.** While transfer learning can converge quickly, 10 epochs with 256 iterations per epoch is very short, and the stability of the results (e.g., whether performance fluctuates across different random seeds) is not assessed.

### Trivial

None.

## Nice-to-Haves

- An ablation study comparing fine-tuning vs. feature extraction (freezing vs. unfreezing different layers) would clarify how much the transfer learning component contributes.
- Visualization tools (e.g., Grad-CAM heatmaps) would help build confidence that the models focus on relevant anatomical regions rather than spurious correlations.
- Providing the exact train/val/test split indices or split-generation script would improve reproducibility.

## Removed Points

*These points were removed per instructions and should be treated with caution.*

- **Checkpoint mechanism biases test performance upward (Harsh Critic).** The critic claimed that selecting the best validation epoch "biases test performance upward." This is standard practice: validation is used for model selection, and a held-out test set provides an unbiased evaluation. The paper describes exactly this procedure. The criticism reflects a misunderstanding of standard evaluation protocols.

- **Missing Figures 5/6 and Table 1 (Harsh Critic).** These are figures embedded as images in the PDF. The parser stripped them but they exist in the original submission. This is a parser artifact, not an author omission.

- **"Inflate" typo in conclusion (Harsh Critic).** The paper says "inflate the robustness" where it likely means "enhance" or "improve." This is either a minor language issue or a parser artifact. Per instructions, formatting/langauge artifacts are removed.

- **Strength: "Near-perfect testing accuracy using transfer learning" (Strength Finder).** This strength conflicts with verified weaknesses (implausibility of 100% accuracy, lack of patient-level split, potential shortcut learning from annotations). Per the rule "when a strength and weakness disagree, the weakness wins," this strength is removed.

- **Strength: "Novel multi-task binary classification design" (Strength Finder).** Splitting a multi-class problem into binary subproblems is a standard design choice, not a novel contribution. This strength is generic and lacks substantive specificity.

## Novel Insights

None beyond the paper's own contributions. The reviews do not surface a perspective that meaningfully reframes or extends what the authors claim.

## Suggestions

1. **Implement a patient-level split** and re-report all results. If the Kaggle dataset already provides patient-level metadata, describe this explicitly. If not, contact the dataset maintainers or derive patient IDs from the file naming conventions.
2. **Check for and remove annotation artifacts.** Inspect all images in the dataset for red marks, text overlays, or bounding boxes. If present, either crop them out, mask them, or exclude affected images from the experiment — and report what was done.
3. **Add at least two simple baselines:** a feature-based classifier (e.g., logistic regression on HOG or texture features) and a small CNN trained from scratch. Report whether transfer learning provides meaningful gains over these baselines.
4. **Report per-task numerical metrics** (accuracy, precision, recall, F1) with confidence intervals from at least 3 runs with different random seeds. Avoid the ambiguous "up to 100%" framing and report the actual numbers, even if they are lower.
5. **Provide the specific training configuration:** optimizer (with hyperparameters), learning rate schedule, batch size, which layers were frozen/unfrozen, and data augmentation pipeline.

## Score and Decision

This paper addresses a relevant clinical problem and uses appropriate architectures, but its central empirical claims are not supported by the evidence provided. The absence of patient-level splitting, the presence of radiologist annotations in sample images without documented preprocessing, the lack of any baseline comparisons, and the absence of statistical confidence measures collectively undermine the credibility of the reported near-perfect accuracy. The paper's contribution cannot be accepted in its current form. A major re-evaluation with proper methodological controls is needed before the results can be trusted.

**Score: 3.0/10** — The motivation and architecture choices are sound, but the evaluation contains serious methodological gaps that invalidate the core empirical contribution as currently presented.

MY FINAL SCORE: <pineapple>3.0</pineapple>
MY FINAL DECISION: <orange>Reject</orange>